PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 7/29

Buckle Up

PharmD_KS's avatar
PharmD_KS
Jul 28, 2026
∙ Paid

If you are looking to join the Discord (separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content, but a Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 7/26

The short setup for NQ played out immediately at open last night as it failed 28228 and trended lower all night (ultimately resolving for 600+ to today’s low) until KOSPI closed with NQ sitting in some demand. There was a relief pop into the open, but NQ opened right in the weekly 27941-27969 level, failed the 27996 honorable mention level for today, and sold straight to the May low which was a major target on continuation below the June low. From the daily plan and weekly plan respectively:

There was some very decent buying at the low and frankly some horrific selling (aggressive in this case at poor location) and the result was a nice cover rally. We did see a fair amount of initiative buying come in as well, forming a double distribution profile to the upside and leaving behind a key area of defense for tomorrow.

ES was firmer overnight but triggered its short just ahead of the open resolving to its target of the weekly 7420-7424 target, falling just short (maddeningly) of yesterday’s low, last week’s low, and the 6/28 week low.

Bulls have a setup to work with tomorrow, with FOMC and earnings after the bell to likely decide matters.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture